Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil.

Thiago Cerqueira-Silva ORCID logo; Srinivasa Vittal Katikireddi ORCID logo; Vinicius de Araujo Oliveira ORCID logo; Renzo Flores-Ortiz ORCID logo; Juracy Bertoldo Júnior; Enny S Paixão ORCID logo; Chris Robertson; Gerson O Penna ORCID logo; Guilherme L Werneck ORCID logo; Maurício L Barreto; +4 more... Neil Pearce ORCID logo; Aziz Sheikh ORCID logo; Manoel Barral-Netto; Viviane S Boaventura ORCID logo; (2022) Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil. Nature Medicine, 28 (4). pp. 838-843. ISSN 1078-8956 DOI: 10.1038/s41591-022-01701-w
Copy

There is considerable interest in the waning of effectiveness of coronavirus disease 2019 (COVID-19) vaccines and vaccine effectiveness (VE) of booster doses. Using linked national Brazilian databases, we undertook a test-negative design study involving almost 14 million people (~16 million tests) to estimate VE of CoronaVac over time and VE of BNT162b2 booster vaccination against RT-PCR-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe COVID-19 outcomes (hospitalization or death). Compared with unvaccinated individuals, CoronaVac VE at 14-30 d after the second dose was 55.0% (95% confidence interval (CI): 54.3-55.7) against confirmed infection and 82.1% (95% CI: 81.4-82.8) against severe outcomes. VE decreased to 34.7% (95% CI: 33.1-36.2) against infection and 72.5% (95% CI: 70.9-74.0) against severe outcomes over 180 d after the second dose. A BNT162b2 booster, 6 months after the second dose of CoronaVac, improved VE against infection to 92.7% (95% CI: 91.0-94.0) and VE against severe outcomes to 97.3% (95% CI: 96.1-98.1) 14-30 d after the booster. Compared with younger age groups, individuals 80 years of age or older had lower protection after the second dose but similar protection after the booster. Our findings support a BNT162b2 booster vaccine dose after two doses of CoronaVac, particularly for the elderly.


picture_as_pdf
Cerqueira-Silva_etal_2022_Vaccine-effectiveness-of-heterologous-coronavac.pdf
subject
Published Version
Available under Creative Commons: 4.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads